Publicaciones en colaboración con investigadores/as de Claude Bernard University Lyon 1 (77)

2024

  1. Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

    Blood, Vol. 143, Núm. 17, pp. 1713-1725

  2. Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine

    The Lancet Respiratory Medicine, Vol. 12, Núm. 4, pp. 305-322

2023

  1. Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial

    Journal of Thoracic Oncology, Vol. 18, Núm. 12, pp. 1731-1742

  2. ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

    Multiple Sclerosis Journal

  3. European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

    European Journal of Neurology, Vol. 30, Núm. 8, pp. 2144-2176

  4. European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors

    International Journal of Gynecological Cancer, Vol. 33, Núm. 10, pp. 1621-1626

  5. Extracorporeal Techniques in Kidney Failure

    Blood Purification, Vol. 53, Núm. 5

  6. Identification of Patients with Early HR+ HER2- Breast Cancer at High Risk of Recurrence

    Geburtshilfe und Frauenheilkunde, Vol. 84, Núm. 2, pp. 164-184

  7. Predictors of treatment switching in the Big Multiple Sclerosis Data Network

    Frontiers in Neurology, Vol. 14

2022

  1. An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    World Journal of Surgery, Vol. 46, Núm. 6, pp. 1336-1343

  2. Autoantibodies against type I IFNs in patients with critical influenza pneumonia

    The Journal of experimental medicine, Vol. 219, Núm. 11

  3. Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection

    Frontiers in Pharmacology, Vol. 13

  4. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

    The Lancet Oncology, Vol. 23, Núm. 8, pp. e374-e384

  5. Intravitreal Corticosteroid Implantation in Diabetic Macular Edema: Updated European Consensus Guidance on Monitoring and Managing Intraocular Pressure

    Ophthalmology and Therapy

  6. Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma

    Dermatologic Therapy

  7. Partial Hydrolyzed Protein as a Protein Source for Infant Feeding: Do or Don’t?

    Nutrients, Vol. 14, Núm. 9

  8. Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

    New England Journal of Medicine, Vol. 386, Núm. 7, pp. 629-639

  9. The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021

    Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 28, Núm. 9, pp. 1424-1456

  10. Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

    Nature Medicine, Vol. 28, Núm. 2, pp. 325-332

2021

  1. COVID-19-associated pulmonary aspergillosis, March-August 2020

    Emerging Infectious Diseases, Vol. 27, Núm. 4, pp. 1077-1086